Baya ga Phillip M. Altman BPharm (Hons) MSc PhD, mawallafa a kan wannan yanki sun haɗa da James Rowe BPharm, MSc, PhD FRSN, Wendy Hoy AO FAA FRACP, Gerry Brady MBBS, Astrid Lefringhausen, PhD, Robyn Cosford MBBS (Hons) FACNEM FASLM, da kuma Bruce RACOG, FRACGP.
Ma'aikatar Tsaro ta Amurka (US DoD) tana da babban matsayi a cikin martani ga ƙwayar cuta ta SARS-CoV-2 da haɓakawa, da rarraba rigakafin Covid 19, gaskiyar da ke ɓoye ga jama'a. A cikin waɗancan matakai da yawa daidaitattun matakai da hanyoyin, in ba haka ba da ake buƙata don samfuran magunguna, an tsallake su ko ketare.
Ma'anar waɗannan alluran rigakafin a matsayin "ma'auni" maimakon magungunan warkewa ya ba da izinin ci gaba da sauri zuwa izinin amfani da gaggawa da kuma fitowa fili. Mummunan sakamako da yawa sun kasance sakamakon wannan martanin soja na sirri game da batun lafiyar jama'a. Me yasa gwamnatoci a duniya, ciki har da Ostiraliya, suke shirin yin ƙarin saka hannun jari a cikin wannan fasahar rigakafin gaggawa da sojojin Amurka ke jagoranta?
Gudun paukar Warp
Tare da Izinin Amfani da Gaggawa na Hukumar Abinci da Magunguna ta Amurka na rigakafin COVID-19 (FDA, 2020) da Yarjejeniyar Gaggawa na rigakafin COVID-19 na farko a Ostiraliya (TGA, 2021), an yaba wa waɗannan wakilai a matsayin sabbin martanin ceton rai ta masana'antar harhada magunguna ga annoba ta duniya.
Haɓaka, gwaji da amincewar ka'idojin magunguna na waɗannan sabbin alluran rigakafin ƙwayoyin cuta na COVID-19 ta amfani da fasahar manzo ribonucleic acid (mRNA) an ce an yi su cikin ƙasa da shekara ɗaya, yayin da haɓakawa da amincewar alluran rigakafi na yau da kullun suna ɗaukar kusan shekaru 10. (Seneff da Nigh, 2021). An shaida wa jama'a cewa tallafin kudi na tallafin kudi na kamfanonin rigakafin da gwamnatin Amurka ta yi a karkashin Operation Warp Speed.
An gaya wa jama'a cewa waɗannan alluran rigakafin cutar ta COVID-19 suna da "lafiya kuma masu tasiri" (CDCa, 2022): cewa za su hana kamuwa da cuta da yiwuwar kamuwa da cuta mai tsanani da mutuwa daga kwayar cutar, kuma za su hana kamuwa da cutar. Yanzu mun san ba sa hana kamuwa da cuta ko watsawa kuma ba su hana ci gaba da kamuwa da COVID-19 ba. Bugu da ƙari kuma suna da alaƙa da abin da ba a taɓa ganin irinsa ba na munanan al'amura da mace-mace idan aka kwatanta da duk wasu magunguna a tarihin masana'antar harhada magunguna. (Turni da Lefringhausen 2022; Altman, 2022; CMN, 2022; Blaylock, 2022).
Dangane da Tsarin Ba da Rahoto Kan Alurar rigakafin Alurar riga kafi na Amurka (VAERS), an sami rahotannin aukuwa mara kyau guda 1,476,227 masu alaƙa da waɗannan “alurar rigakafi” (CDC).b, 2022). har zuwa Disamba 2, 2022, wanda ya haɗa da 32,621 da aka bayar da rahoton mutuwar da 185,412 asibiti. Bugu da ƙari kuma, an ba da rahoton karuwar mace-macen da ba a bayyana ba a duniya a daidai lokacin da aka gabatar da su. A Ostiraliya, har zuwa Agusta 2022 an sami asarar rayuka 18,671 (kashi 17) fiye da matsakaici, tare da yawancin waɗannan mutuwar ba saboda COVID-19 (ABS, 2022). Wataƙila muna fuskantar bala'in lafiya mafi muni a tarihi.
Ta yaya masana'antar harhada magunguna, gwamnatocinmu da masu kula da magunguna suka yi kuskure haka? Amsa mai ma'ana ga wannan tambayar ta fito cikin 'yan makonnin da suka gabata.
Rundunar Tsaro ta Kasa
Sabanin sanannen imani cewa kamfanonin harhada magunguna sun kori shirye-shiryen haɓaka rigakafin COVID, gidan yanar gizon FDA na Amurka (FDA, 2020) ya bayyana cewa Ma'aikatar Tsaro ta Amurka (DoD) ta kasance mai cikakken iko kan shirin ci gaban rigakafin Covid tun farkonsa. DoD ita ce ke da alhakin haɓakawa, masana'antu, gwaje-gwaje na asibiti, tabbacin inganci, rarrabawa da gudanarwa, tun daga wancan lokacin (FDA, 2020; Rees da Latypova, 2022; KEI, 2022; Consortium Defence Medical, 2022; Rees, 2022). Manyan kamfanonin harhada magunguna sun shiga hannu a matsayin “Ƙungiyoyin Haɗin Kan Ayyuka” suna yin aiki yadda ya kamata a matsayin masu kwangila ga DoD. Babban Jami'in Gudanarwa na shirin rigakafin Gudun Warp shine Ma'aikatar Tsaro ta Amurka, kuma Babban Mashawarcin Kimiyya shine Ma'aikatar Lafiya da Ayyukan Dan Adam (HHS).
Yanayin Alurar rigakafin Halittu
Kafofin watsa labarai na yau da kullun, manyan kamfanonin harhada magunguna da gwamnatoci sun ba da cikakken bayanin ainihin yanayin COVID-19 'alurar rigakafi' kuma yawancin jama'a ba su fahimce shi ba. Magana ga waɗannan samfuran a matsayin "alurar rigakafi" ya sa yawancin mutane ɗaukar su a matsayin mai aminci da ingantaccen bincike kuma cikin yarda da amfani da su. Duk da haka, ba ainihin maganin rigakafi ba ne - su ne manyan abubuwan da suka shafi kwayoyin halitta waɗanda ba a taɓa yin amfani da su sosai a cikin kowace al'umma ba, musamman ma ga mutane masu lafiya ciki har da yara, jarirai da mata masu ciki. A wannan ma'anar ya kamata a dauke su a matsayin gwaji.
COVID-19 'alurar rigakafi' sun fada cikin wani nau'i na musamman na magungunan warkewa a ƙarƙashin Ofishin Amurka na FDA na Cellular, Tissue da Gene Therapies' wanda aka ayyana a matsayin "kayayyakin jiyya," wanda ya ƙunshi "gabatar da wani sabon ko ingantaccen kwayar halitta a cikin jiki don taimakawa wajen magance wata cuta" (FDA, 2018). A yanzu, an iyakance amfani da samfuran maganin ƙwayoyin cuta ga maganin cututtukan da ba kasafai ba, mai tsanani da rauni ko yanayin kwayoyin halitta. Suna da yuwuwar haifar da lahani na dindindin tsakanin tsararraki, ciwon daji da tsoma baki tare da iyawar haihuwa.
FDA da sauran hukumomin kula da magunguna suna da ƙayyadaddun ƙa'idodi da jagororin don jagorantar masana'antun a cikin haɓakawa da gwajin irin waɗannan samfuran, don duka daidaitattun (FDA, 2013) da bincike na asibiti (FDA, 2015). Koyaya, FDA ba ta kimanta waɗannan COVID-19 "alurar rigakafi" bisa ga waɗannan jagororin jiyya na kwayoyin halitta ba.
Madadin haka, an yi yunƙurin haɗin gwiwa don guje wa ambaton su azaman samfuran jiyya na ƙwayoyin cuta, bisa, a wani ɓangare, kan hujjar cewa ba a yi nufin shigar da kwayoyin halitta a cikin allurar COVID-19 a cikin DNA na mutum ba, ko kuma don canza maganganun kwayoyin halitta. Babu bayanan aminci na ɗan gajeren lokaci da kuma bayanan dogon lokaci akan abin da za'a iya hasashen tasirin gaba. Ba a taɓa yarda da irin waɗannan samfuran warkewa a baya a ko'ina cikin duniya ba. Gudanarwarsu ta yaɗu a duniya ba tare da ƙwarewar tsaro ta tarihi wani haɗari ne da ba a taɓa ganin irinsa ba a lafiyar ɗan adam.
Hanzarta Ci Gabanta
DARPA (Hukumar Binciken Cigaban Ayyukan Tsaro) ta yi bincike a kan fasahar dandalin Messenger RNA tun aƙalla 2012 (McCullough, 2022). A farkon 2020, a cikin firgita don haɓaka rigakafin COVID-19, an cire wasu mahimman bincike da hanyoyin haɓakawa, ƙetare, taƙaice, ko kuma ba a yi su cikin ma'ana mai ma'ana ba, ko ga kafa dakin gwaje-gwaje ko matakan masana'antu. Kodayake furotin mai karu shine magani mai aiki kuma yana da alhakin amsawar rigakafi kai tsaye, ilimin harhada magunguna da toxicology ba a yi nazarin dabbobi ko a cikin mutane kamar yadda ake buƙata ba.
Sauran fitattun rashi sun haɗa da rashin bincike mai mahimmanci akan ciwon daji, mutagenicity, genotoxicity da ilimin haifuwa a cikin nau'in dabba masu dacewa. Musamman ma, ba a bincika yuwuwar juyar da rubutun kwayoyin halittar mRNA zuwa DNA na mutum ba. Bugu da ƙari, masana'antar haɓaka haɓaka ta kasance da wuri kuma ba ta da isasshen iko don tabbatar da cewa samfurin da aka yi a cikin manyan batches iri ɗaya ne da waɗanda aka yi a cikin ƙananan batches.
Idan ba tare da irin wannan binciken ba, ƙarfin, amincin mRNA, kasancewar gurɓatawa da kwanciyar hankali na "alurar rigakafi" ba za a iya ba da tabbacin ba. Irin waɗannan sa ido suna da alhakin gazawar yin hasashen mummunan halayen miyagun ƙwayoyi da mace-mace waɗanda yanzu aka bayar da rahoton dangane da waɗannan alluran rigakafin..
Don rage haɗari, shirin a cikin ci gaban rigakafin shine amfani da fasahohi da yawa, wurare da yawa da sake sakewa. Hakanan za'a yi amfani da kayan aikin da ake dasu. Dangane da abin da ya dace, shirin ya kasance don kauce wa amfani da hanyoyin gargajiya tun daga farkon farawa zuwa samar da manyan kayayyaki. Nisantar ingantattun ka'idoji da jagororin kamar Kyawawan Kyawawan Kyawawan Ayyuka da Jagororin Ayyukan Laboratory ya zama dole don saurin haɓakawa, kuma an keta izinin aikace-aikacen lasisin New Drug na al'ada (NDA) da Biologics License Application (BLA).
Madadin haka, tsarin ya motsa cikin sauri ta amfani da matsayayyun layukan lokaci da matakan ci gaba zuwa ga Izinin Amfani da Gaggawa (EUA). An tsara sikeli da manyan masana'anta a cikin layi daya tare da, maimakon a da, gwaje-gwajen asibiti waɗanda, sake, ƙila sun saba wa ka'idojin da aka yarda da su na Kyawawan Ayyukan Masana'antu. Wataƙila waɗannan hanyoyin sun kasance girke-girke na yuwuwar bala'i. (Latypova, 2022; Watt da Latypova, 2022).
Tsarin Shari'a
Mahimman abubuwan majalisu suna baiwa gwamnatin Amurka damar ba da izini, ba da kuɗi, kwangila da sarrafa yawancin shirye-shiryen bincike na DoD, kamar haka:
- Dokokin ba da izini na Amfani da gaggawa (1997) sun ba da damar, a lokuta na gaggawa, sabon magani da za a samar tare da ƙarancin aminci da ingantaccen bayanai fiye da yadda ake buƙata don cikakken yarda.
- Sauran ka'idojin Hukumar Ma'amala (2015) sun ba da izinin ma'amalar kwangilar da ba a buƙata don bin dokokin tarayya da ƙa'idodi, da
- Dokar Shirye-shiryen Jama'a da Shirye-shiryen Gaggawa (Dokar PREP 2020) ta kafa ƙayyadaddun alhaki ga kamfanonin da ke cikin shirye-shiryen kwangila tare da DoD.
Hukumomin DoD guda biyu na Amurka, Hukumar Ayyukan Bincike na Ci Gaban Tsaro (DARPA) da Hukumar Bincike da Ci Gaban Halitta (BARDA), suna da albarkatu masu yawa don bincike, haɓakawa da amincewa ga samfura daban-daban. Suna kuma yin kwangila tare da kamfanoni masu yawa don irin waɗannan ayyuka.
Samfuran waɗannan shirye-shiryen, gami da allurar COVID-19, wani lokaci ana rarraba su azaman “maganin rigakafi,” “samfuri,” ko “muna-nuna” maimakon samfuran magunguna. Waɗannan alamun suna ba da izinin samfur don guje wa dogayen tsari na al'ada, haɓaka kasuwanci da hanyoyin gwaji waɗanda aka saba buƙata don samfuran magunguna (ICH, 2022) kuma don ci gaba zuwa Izinin Amfani da Gaggawa.
Rush zuwa Manyan Manufacturer
Yunkurin samar da allurar rigakafin cutar ta Covid ya haifar da sauye-sauyen tsari-zuwa-tsalle, tare da wasu batches da ke da alaƙa da babban abin da ke haifar da munanan halayen rigakafi da mace-mace (Gutschi, 2022). Bugu da kari, aƙalla 26 masu bincike / kungiyoyin bincike a cikin kasashe 16, kuma a jinin mutane da yawa, wanda babu bayani mai gamsarwa a wannan lokacin. Bugu da ƙari, hanyoyi daban-daban na bincike sun gano kasancewar ƙananan ƙarfe da ba a bayyana ba da kuma ba zato ba tsammani. (Rukunin Aiki na Jamus, 2022; Hughes, 2022).
A cikin yanayi na yau da kullun, ko da ɗan ƙaramin ɗan ƙaramin ingancin da aka ruwaito, inganci ko matsalolin aminci da ke da alaƙa da rigakafin Covid sun haifar da janyewar su nan da nan, amma hakan bai faru ba. Masu sarrafa magunguna a duniya da alama sun makance da gangan ga matsalolin. Gwamnatoci da kafafen yada labarai na yau da kullun ba su nuna sha'awar fallasa gaskiya ko gudanar da muhawarar jama'a kan waɗannan batutuwa masu mahimmanci ba. Me yasa?
Amsar da alama ita ce, a cikin sha'awar tsaron ƙasa, US DoD ta ɗauki nauyin bayar da tallafin rigakafi na Covid, haɓakawa da gwaji tun farkon barazanar da ake gani a farkon 2020. A cikin firgici na farko, ingancin hankali na yau da kullun, aminci da ingantaccen la'akari sun lalace. Masu kula da magunguna sun taka, kuma suna ci gaba da taka rawa, rawar da za ta taka wajen amincewa da amincewa da waɗannan alluran rigakafin. Yanzu mun ga wannan kuskure ne. Mutane da yawa a yanzu suna da ra'ayin cewa allurar rigakafin Covid sun bayyana sun yi lahani fiye da mai kyau (Dopp da Seneff, 2022). Gano gaskiya ya kasance cikin tafiyar hawainiya da wahala, abin da ya kara ta’azzara saboda tsantsauran ra’ayi da ba a taba ganin irinsa ba na likitoci da masana kimiyya, wanda ya ci gaba har yau.
Kammalawa
Tambayoyi da yawa sun taso game da allurar COVID game da rashin isassun ayyukan masana'antu, kula da inganci, ilimin likitanci na asali da na toxicological da rashin ingantaccen amincin asibiti da nazarin inganci. Hukumomin kula da magunguna da alama suna jinkirin amincewa da matakin da ba a taɓa ganin irinsa ba na munanan halayen miyagun ƙwayoyi da kuma mutuwar da ke tattare da waɗannan samfuran. Hakanan akwai damuwa sosai game da karuwar mace-mace daga dukkan dalilai a cikin ƙasashe da yawa tare da yin amfani da su. Hukumomin lafiyanmu sun ƙi yin la'akari da cewa maganin da kansu na iya zama laifi.
An gaya wa jama'a waɗannan alluran rigakafin na COVID suna "lafiya kuma masu tasiri" ba tare da cancanta ba duk da cewa ba a yarda da su gaba ɗaya ba. Me ya sa ba a bai wa jama'a shawarar cewa ba a yi amfani da ka'idojin inganci, aminci da inganci ba wajen haɓakawa da gwada waɗannan alluran rigakafin? Me ya sa aka ɓoye wannan? Me yasa gwamnatoci a duniya, ciki har da Ostiraliya, suke shirin yin ƙarin saka hannun jari a wannan fasahar rigakafin rashin aminci? Shin waɗannan shirye-shiryen tsaron ƙasa za su kasance a wurin don rigakafin rigakafi da sauran samfuran magunguna nan gaba?
Makomar bil'adama da dukkanin al'ummomi masu zuwa a zahiri suna cikin wani muhimmin matsayi kuma 'yan dillalan ikon duniya da masu yanke shawara na siyasa sun bayyana sun fahimci girman lamarin.
References
- Altman P, Rowe J, Hoy WE, Brady G, Lefringhausen A, Cosford R, Wauchope B. Shin Ma'anar Tsaro ta Kasa ta Haɓaka Tsaron rigakafin Covid-19?
- Makarantun Kimiyya na Kasa, Injiniya, da Magunguna; Rarraba kan Duniya da Nazarin Rayuwa; Hukumar akan Kimiyyar Rayuwa; Kwamitin Kimiyyar Kimiyya da Fasaha; Kwamitin kan Dabaru don Ganewa da Magance Matsalolin Matsalolin Kariyar Kwayoyin Halittu da Haihuwar Halittar Halittar Halittu.Washington (DC): National Academy Press (US); 2018 ga Yuni 19.https://www.ncbi.nlm.nih.gov/books/NBK535870/
- Rahoton Blaylock - COVID-19 “Alurar rigakafi: Menene gaskiya? Jaridar Duniya ta Ka'idar Alurar riga kafi, Ayyuka da Bincike 21 Satumba 2022. https://ijvtpr.com/index.php/IJVTPR/article/view/57
- CDCa - Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka - Amintattun allurar COVID-19 da aka sabunta Dec. 5 2022. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/safety-of-vaccines.html
- CDCb - Cibiyoyin Kula da Cututtukan Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar (VAERS) har zuwa Disamba 2, 2022. Buɗe bayanan VAERS. https://openvaers.com/covid-data
- Cosentino, M .da Marino, F.: Fahimtar ilimin Pharmacology na COVID-19 mRNA Vaccines: Wasa Dice tare da Spike? Int. J. Mol. Sci. 2022, 23, 10881. https://doi.org/10.3390/ijms231810881
- Dopp, K. da Seneff, S: COVID-19 da Duk-Dalilin Bayanan Mutuwa ta Ƙungiyar Zamani ta Bayyana Hadarin Cutar Cutar Cutar Cutar Cutar Cutar Kwalara ta Daidaita ko Yafi Haɗarin Mutuwar COVID ga duk Ƙungiyoyin Shekarun da ke ƙasa da Shekaru 80 kamar na 6 ga Fabrairu 2022. https://vixra.org/pdf/2202.0084v1.pdf
- Sanarwa na FDA 2020
https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid
- FDA - Kwamitin Ba da Shawarar Alurar rigakafin Amurka da Abubuwan Halittu masu alaƙa Oktoba 22, 2020 Gabatarwar Taro - Gudun Aikin Warp - Gudanarwa don Shirye-shiryen Dabaru da Amsa - Takaddun da ba a bayyana ba daga Yanar Gizon FDA na Amurka (bayan “Gabatarwa FDA”) https://www.fda.gov/media/143560/download
- FDA Agusta 2018: FDA ta amince da farkon nau'in maganin RNA da aka yi niyya don magance wata cuta da ba kasafai ba. https://www.fda.gov/news-events/press-announcements/fda-approves-first-its-kind-targeted-rna-based-therapy-treat-rare-disease
- Rukunin Aiki na Jamus don Binciken Alurar rigakafin COVID - Takaitaccen Bincike na Farko - Yuli 6, 2022. https://guerrillatranscripts.substack.com/p/german-working-group-for-covid-vaccine
- Gutschi, M.: Batutuwa masu inganci tare da Samar da rigakafin mRNA Covid. 2 Nuwamba 2022. https://www.bitchute.com/video/muB0nrznCAC4/
- Hughes, D.: Menene a cikin abin da ake kira COVID-19 "Alurar rigakafi"? Sashe na 1: Shaidar Laifin Duniya Ga Bil Adama. Jarida ta Duniya na Ka'idar Alurar riga kafi, Ayyuka, da Bincike 2(2), Satumba 3, 2022 Shafi na 455 https://doi.org/10.56098/ijvtpr.v2i2
- Taron kasa da kasa kan daidaitawa - https://www.ich.org/page/ich-guidelines
- Knowledge Ecology International (KEI) - Kwangilolin COVID https://www.keionline.org/covid-contracts
- Latypova, S.- https://www.bitchute.com/video/BGIqC6ufcyjF/ Hirar Bitchute Oct. 25 2022
- McCullough, P: mRNA da DNA vector allurar rigakafin da DARPA (Hukumar Kula da Ayyukan Bincike na Tsaro) suka yi - 3speak.tv Disamba 2022. https://3speak.tv/watch?v=rairfoundation/idclxvii
- Ƙungiyar Tsaron Kiwon Lafiya - https://www.medcbrn.org/current-members/https://www.medcbrn.org/about-mcdc/
- Pfizer bai sani ba ko maganin Covid ya dakatar da watsawa kafin fitowa, in ji shugaban. News.com.au Oktoba 13, 2022. https://www.news.com.au/technology/science/human-body/pfizer-did-not-know-whether-covid-vaccine-stopped-transmission-before-rollout-executive-admits/news-story/f307f28f794e173ac017a62784fec414
- Buɗe Wasika daga Cibiyar Kula da Lafiya ta Covid (CMN) Zuwa Ƙungiyar Ba da Shawarar Fasaha ta Australiya akan Rigakafi (ATAGI), Hukumar Kula da Kaya ta Ostiraliya (TGA) da Sashen Lafiya na Tarayyar Australiya. 8 Maris 2022 https://www.covidmedicalnetwork.com/open-letters/open-letter-to-atagi.aspx
- Prep ACT rigakafi daga alhaki ga COVID-19 allurar rigakafi. Ma'aikatar Kiwon Lafiya da Ayyukan Jama'a ta Amurka. Maris 2020. https://www.phe.gov/emergency/events/COVID19/COVIDVaccinators/Pages/PREP-Act-Immunity-from-Liability-for-COVID-19-Vaccinators.aspx
- Rees, H. da Latypova, S. Toxic by Design: Manyan masanan Pharma sun yi magana a ranar 22 ga Nuwamba 2022. https://www.ukcolumn.org/video/toxic-by-design-big-pharma-experts-speak-out
- Seneff, S. da Nigh, G.: Mafi muni fiye da cutar? Bita Wasu Matsalolin da Ba a Yi Niyya ba na allurar mRNA Akan COVID-19. Jarida ta Duniya na Ka'idar Alurar riga kafi, Ayyuka, da Bincike 2(1), Mayu 10, 2021
- TGA ta amince da Pfizer COVID-19 na ɗan lokaci. 27 ga Agusta, 2021. https://www.tga.gov.au/news/media-releases/tga-provisionally-approves-pfizer-covid-19-vaccine
- Turni, C da Lefringhausen, A.: COVID-19 alluran rigakafi - Binciken Ostiraliya. Jaridar Clinical and Experimental Immunology, Vol. 7, Fitowa ta 3, p491. 21 ga Satumba, 2022. https://doi.org/10.33140/jcei.07.03.03
- Ma'aikatar Tsaro ta Amurka - Alexandra (Sasha) Latypova - 4 ga Nuwamba 2022 https://zeeemedia.com/interview/uncensored-bombshell-team-enigma-whistleblower-us-dod-plan-to-exterminate-population-sasha-latypova/
- Watt, K. da Latypova, S. - Nuwamba 8, 2022 https://rumble.com/v1sjz4u-tattaunawa-with-Katherine-Watt game da-American-domestic- bioterrorism-pro.html
-
Phillip Altman masanin harhada magunguna ne kuma mai ba da shawara kan harkokin magunguna a Melbourne, Ostiraliya.
Duba dukkan posts
